Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010010
Filing Date
2025-05-13
Accepted
2025-05-13 17:17:35
Documents
44
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10-q.htm   iXBRL 10-Q 460585
2 CERTIFICATION ex31-1.htm EX-31.1 11372
3 CERTIFICATION ex31-2.htm EX-31.2 17490
4 CERTIFICATION ex32-1.htm EX-32.1 5487
  Complete submission text file 0001641172-25-010010.txt   2510275

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cqens-20250331.xsd EX-101.SCH 21332
6 XBRL CALCULATION FILE cqens-20250331_cal.xml EX-101.CAL 36624
7 XBRL DEFINITION FILE cqens-20250331_def.xml EX-101.DEF 64949
8 XBRL LABEL FILE cqens-20250331_lab.xml EX-101.LAB 199824
9 XBRL PRESENTATION FILE cqens-20250331_pre.xml EX-101.PRE 145257
46 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 234274
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 25941394
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)